Found 67 matching trials
Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy PHASE1 This study will assess the reno-protective effect of renin inhibition with ...
Show More Learn More & Join Trial
Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome PHASE4 This proof of concept study is designed to evaluate the efficacy and safety...
Show More Location
Addenbrookes Hospital
Learn More & Join Trial
Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension PHASE3 The purpose of the study was to evaluate the efficacy (blood pressure lower...
Show More Location
Investigative Site
Learn More & Join Trial
Role of ALiskiren, a Direct Renin Inhibitor, in Preventing Atrial Fibrillation in Patients With a Pacemaker; RALF. PHASE3 The aim of the study is to find out whether aliskiren reduces atrial fibril...
Show More Location
Helsinki University Central Hospital
Learn More & Join Trial
Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet PHASE3 This study will measure the effects of different doses of aliskiren on kidn...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure PHASE3 This study evaluated the effect of early initiation of aliskiren therapy, c...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of Aliskiren 75 mg, 150 mg, and 300 mg in Elderly Patients With Essential Hypertension When Given With a Light Meal in a 8 Week Placebo-controlled Study PHASE3 This study will evaluate the efficacy and safety of aliskiren 75 mg, 150 mg...
Show More Location
Investigative Site
Learn More & Join Trial
Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients PHASE4 This prospective multicenter, double blind study will evaluate the efficacy...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure. PHASE3 Evaluate the blood pressure lowering effect of aliskiren 150mg, 300mg and 6...
Show More Location
Novartis Pharmaceuticals
Learn More & Join Trial
Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE) PHASE3 The core and extension studies assessed the safety and efficacy of aliskire...
Show More Learn More & Join Trial